News
The U.S. FDA approved Phraxis Inc.’s Endoforce Connector for endovascular venous anastomosis, which eliminates the need for surgical dissection for individuals undergoing hemodialysis for kidney ...
MINNEAPOLIS, May 22, 2025 /PRNewswire/ -- Phraxis Inc., a Minneapolis -based medical device company, marks a major milestone ...
Phraxis Inc., a Minneapolis-based medical device company, marks a major milestone with FDA approval of the EndoForcetm Connector for Endovascular Venous Anastomosis (EndoForcetm) ? a pivotal ...
Phraxis Inc. announced FDA approval of the EndoForce connector for endovascular venous anastomosis for dialysis access in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results